Chroust Karel ( search by name in IS MU /auth )

Body na spoluautora Body za publikaci pro MU Odkaz ISVaV
0,40 2,81 Nový informační systém a datový audit cervikálního screeningu v ČR
1,42 14,25 Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results
25,42 101,67 Increasing the infliximab dose in rheumatoid arthritis patients: a randomized, double blind study failed to confirm its efficacy.
0,00 0,00 Použití metod SSCP a TGGE pro screening kandidátních genů LQTS
0,00 0,00 Mutation analysis of candidate genes SCN1B, KCND3 and ANK2 in patients with clinical diagnosis of Long QT syndrome.
20,24 80,97 CORD comparison of recomended dose IA.
0,64 3,81 Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA
7,10 56,80 Quantitative Structure-Activity Relationships for Toxicity and Genotoxicity of Halogenated Aliphatic Compounds: Wing Spot Test of Drosophila melanogaster.
Back
(c) Michal Bulant, 2011